48 related articles for article (PubMed ID: 12924663)
1. Hyperlipasemia Sans Pancreatitis: A Case Series.
George J; Gnanamoorthy K; Suthakaran PK; Baliga KV
Cureus; 2023 Oct; 15(10):e47781. PubMed ID: 38021537
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Disease Spectrum in Hospitalized Cats with Hyperlipasemia: Pancreatitis Alone Is Rare, Hyperlipasemia without Suspected Pancreatitis Is Common.
Hotz V; Brugger D; Kook PH
Animals (Basel); 2024 May; 14(10):. PubMed ID: 38791696
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander?
Goyal H; Sachdeva S; Perisetti A; Mann R; Inamdar S; Tharian B
Gastroenterology; 2021 Feb; 160(3):946-948.e2. PubMed ID: 33129845
[No Abstract] [Full Text] [Related]
4. Non-pancreatic hyperlipasemia: A puzzling clinical entity.
Feher KE; Tornai D; Vitalis Z; Davida L; Sipeki N; Papp M
World J Gastroenterol; 2024 May; 30(19):2538-2552. PubMed ID: 38817657
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Pancreatic Cancer: Emerging Role of Viral Hepatitis.
Gheorghe G; Diaconu CC; Ionescu V; Constantinescu G; Bacalbasa N; Bungau S; Gaman MA; Stan-Ilie M
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055398
[TBL] [Abstract][Full Text] [Related]
6. Elevated Pancreatic Enzymes in ICU Patients With COVID-19 in Wuhan, China: A Retrospective Study.
Ding P; Song B; Liu X; Fang X; Cai H; Zhang D; Zheng X
Front Med (Lausanne); 2021; 8():663646. PubMed ID: 34485322
[No Abstract] [Full Text] [Related]
7. Significant elevations of serum lipase not caused by pancreatitis: a systematic review.
Hameed AM; Lam VW; Pleass HC
HPB (Oxford); 2015 Feb; 17(2):99-112. PubMed ID: 24888393
[TBL] [Abstract][Full Text] [Related]
8. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.
Huang J; Magnusson M; Törner A; Ye W; Duberg AS
Br J Cancer; 2013 Nov; 109(11):2917-23. PubMed ID: 24178755
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies.
Xu JH; Fu JJ; Wang XL; Zhu JY; Ye XH; Chen SD
World J Gastroenterol; 2013 Jul; 19(26):4234-41. PubMed ID: 23864789
[TBL] [Abstract][Full Text] [Related]
10. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
Woo SM; Joo J; Lee WJ; Park SJ; Han SS; Kim TH; Koh YH; Kim HB; Hong EK
J Korean Med Sci; 2013 Feb; 28(2):247-51. PubMed ID: 23400555
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic involvement in chronic viral hepatitis.
Katakura Y; Yotsuyanagi H; Hashizume K; Okuse C; Okuse N; Nishikawa K; Suzuki M; Iino S; Itoh F
World J Gastroenterol; 2005 Jun; 11(23):3508-13. PubMed ID: 15962364
[TBL] [Abstract][Full Text] [Related]
13. Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.
Reisler RB; Murphy RL; Redfield RR; Parker RA
J Acquir Immune Defic Syndr; 2005 Jun; 39(2):159-66. PubMed ID: 15905731
[TBL] [Abstract][Full Text] [Related]
14. Hyperlipasemia associated with hepatitis C virus.
Yoffe B; Bagri AS; Tran T; Dural AT; Shtenberg KM; Khaoustov VI
Dig Dis Sci; 2003 Aug; 48(8):1648-53. PubMed ID: 12924663
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
16. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
17. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
Pár A
Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
Scott LJ; Perry CM
Drugs; 2002; 62(3):507-56. PubMed ID: 11827565
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
